MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517014430 A) filed by Remegen Co. Ltd., Shandong, China, on Feb. 19, for 'il-15 agonists for cancer.'
Inventor(s) include Wang, Zhulun; Min, Xiaoshan; and Chen, Hang.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "Provided herein are IL-15/IL-15Ra-Fc fusion proteins that comprise an IL-15 receptor alpha sushi domain, an IL-15 C-terminal domain, an IL-15 N-terminal domain; and an Fc domain. Further provided are methods of using such IL-15/IL-15Ra-Fc to treat diseases and disorders, such as cancer."
The patent application was internationally fi...